| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Hashimoto thyroiditis | 0.505 | 0.731 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 2002 | 2019 | |||||||||
|
Vitiligo | 0.729 | 0.269 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2005 | 2020 | |||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2010 | 2014 | |||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2010 | 2012 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2009 | 2019 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.020 | None | < 0.001 | 2 | 0 | 1977 | 1980 | |||||||||
|
major histocompatibility complex, class II, DR beta 4 | 0.565 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2006 | |||||||||
|
major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2010 | 2019 | |||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2017 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2017 | |||||||||
|
autoimmune susceptibility 1 | 0.861 | 0.115 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2003 | |||||||||
|
microRNA 196a-2 | 0.599 | 0.577 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 2013 | 2015 | |||||||||
|
microRNA 211 | 0.552 | 0.577 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2017 | |||||||||
|
MHC class I polypeptide-related sequence C (pseudogene) | 0.890 | 0.154 |
|
disease | 0.100 | None | 1.000 | 1 | 3 | 2010 | 2010 | |||||||||
|
microRNA 3940 | 0.861 | 0.154 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
ATP6V1G2-DDX39B readthrough (NMD candidate) | 0.769 | 0.423 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | |||||||||
|
PPT2-EGFL8 readthrough (NMD candidate) | 0.792 | 0.462 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2010 | 2010 | |||||||||
|
long intergenic non-protein coding RNA 1149 | 0.792 | 0.346 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | |||||||||
|
HLA complex group 9 | 0.700 | 0.500 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2010 | 2010 | |||||||||
|
RERE antisense RNA 1 | 0.890 | 0.077 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
LINC02210-CRHR1 readthrough | 0.570 | 0.692 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 2356 | 0.931 | 0.115 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 2570 | 0.931 | 0.115 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | |||||||||
|
long intergenic non-protein coding RNA 2571 | 0.743 | 0.500 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | |||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 |